Form D · Pharmaceuticals
Cadence Health, Inc.
Houston, TX · CIK 0001732157
Offering snapshot reported Jun 16, 2020 · SEC filing
- Reported sold
- $3.1M Offering amount: $16.5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 2, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 16, 2020 | Initial | $3,100,000 | No comparison | 3 | SEC filing |
| Aug 27, 2019 | Initial | $6,271,813 | No comparison | 16 | SEC filing |
| Feb 22, 2018 | Initial | $4,472,993 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-369086
Source: Form D, filed Jun 16, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Abagail Disney | Director |
| Abigail Disney | Director |
| Robert Anthony Hosang | Director, Executive |
| Timothy Koogle | Director |
| Samantha Miller | Executive |
| Nathalie Molina Nino | Director |
| David Malcolm Potts | Director, Executive |
| D. Malcolm Potts | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
C/O Charles D. Powell 1301 Mckinney Street, Suite 5100
Houston, TX, 77010
Houston, TX, 77010